Effect of Stellate Nerve Block in Dysphagia

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

May 4, 2023

Study Completion Date

May 28, 2023

Conditions
Dysphagia
Interventions
PROCEDURE

Injection

The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck.

DRUG

Lidocaine Hydrochloride

the patients were provided with Stellate ganglion block, using 1.5ml of 2% Lidocaine hydrochloride (1ml: 0.5mg) and 500ug of Vitamin B12 (1ml: 0.5g)

BEHAVIORAL

Comprehensive therapy

All the participants are provided with the comprehensive rehabilitation (routine rehabilitation and swallowing function training). The routine rehabilitation included intervention for risk factors (blood pressure, blood lipids, blood glucose, smoking and alcohol restriction, exercise, etc.).

BEHAVIORAL

placebo

The percutaneous approach via the paratracheal route was used for Stellate ganglion block. The operator stood on the side of the block, instructed the patient to lie supine with a thin pillow placed below the shoulders, and tilted the head 45° towards the blocked side, fully exposing the neck. Then, routine disinfection of the neck skin was performed. The puncture site was located 2.5 cm above the sternoclavicular joint and 1.5 cm lateral to the midline of the neck. Only normal saline was used

Trial Locations (1)

Unknown

Huimin Hos., Pengfu

All Listed Sponsors
lead

Copka Sonpashan

OTHER_GOV

NCT06335316 - Effect of Stellate Nerve Block in Dysphagia | Biotech Hunter | Biotech Hunter